Skip to main content

Advertisement

Table 1 Laboratory characteristics of the participants

From: Single and combined use of red cell distribution width, mean platelet volume, and cancer antigen 125 for differential diagnosis of ovarian cancer and benign ovarian tumors

Variables ovarian cancer benign ovarian tumors controls P-value
Number 326 290 162  
Age(years) 43.15 ± 11.59 43.18 ± 9.25 44.13 ± 6.90 0.544
W; (109/L) 8.28 ± 4.01a 6.69 ± 2.25 6.33 ± 1.49c <0.001
N; (109/L) 6.11 ± 4.04a 4.12 ± 2.01 3.70 ± 1.12c <0.001
L; (109/L) 1.52 ± 0.68a 1.97 ± 0.67 2.07 ± 0.72c <0.001
Mo; (109/L) 0.49 ± 0.01a 0.45 ± 0.15 0.44 ± 0.15c 0.001
Hb; (g/L) 106.38 ± 19.53a 124.64 ± 13.13 128.14 ± 6.47c <0.001
PLT; (1012/L) 216.50 ± 130.92a 239.68 ± 88.08 248.18 ± 64.8c 0.001
MPV; (fl) 8.19 ± 0.86a 9.31 ± 0.91b 9.64 ± 0.63c <0.001
PDW;(%) 0.16 ± 0.01a 0.16 ± 0.02b 0.16 ± 0.01c <0.001
RDW;(%) 0.16 ± 0.02a 0.14 ± 0.01b 0.13 ± 0.01c <0.001
CA125; U/mL 68.85(32.20–385.05)a 23.15(14.43–37.76) 5.94(4.04–13.94)c <0.001
  1. Data are expressed as mean ± standard deviation or median (interquartile range)
  2. W, white blood cell count; N, absolute neutrophil count; L, absolute lymphocyte count; Mo, absolute monocyte count; Hb, hemoglobin; PLT, blood platelet count; MPV, mean platelet volume; PDW, platelet distribution width; RDW, red cell distribution width; CA125, cancer antigen 125
  3. P values were calculated by one-way ANOVA tests
  4. aIndicates a significant difference (P < 0.05) between ovarian cancer and benign ovarian tumors (Tukey’s test)
  5. bIndicates a significant difference (P < 0.05) between benign ovarian tumors and controls (Tukey’s test)
  6. cIndicates a significant difference (P < 0.05) between ovarian cancer and controls (Tukey’s test)
  7. 109,10^9; 1012,10^12